Skip to content

Clinical efficacy and mechanism of repetitive transcranial magnetic stimulation in patients with depression during pregnancy and childbirth

Clinical efficacy and mechanism of repetitive transcranial magnetic stimulation in patients with depression during pregnancy and childbirth

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600118228
Enrollment
Unknown
Registered
2026-02-03
Start date
2026-02-03
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perinatal Depression

Interventions

Treatment group:2-week rTMS treatment
Observation group:Blank Observation Period

Sponsors

Chengdu High-tech Zone Women and Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. According to the Structured Clinical Interview for DSM-V (SCID-I), diagnosed by a professional psychiatrist, it was confirmed as Major Depressive Disorder (MDD); 2. The first onset without any treatment; 3. Score of the Self-Rating Depression Scale (SDS) >= 53 points; 4. Score of the Edinburgh Postnatal Depression Scale (EPDS) >= 13; 5. Clinical Global Impression Severity Scale (CGI-S) >= 3; 6. Right-handed, with normal intelligence, vision and hearing. 7. Clear consciousness, able to understand the purpose of treatment, procedures and related risks.

Exclusion criteria

Exclusion criteria: 1. History of PTB; 2. Seizures in oneself or a first-degree relative; 3. There are metal or electronic devices in the brain (including cochlear implants, implanted brain stimulators or electrodes, aneurysm clips, etc.), cochlear implants, pacemakers, coronary stents, etc 4. Severe heart disease; 5. The fetus has known abnormalities; 6. Known obstetric complications include:; Hypertension during pregnancy or diabetes or abnormal prenatal examination; 7. History of drug or alcohol abuse in the past six months; 8. Lifetime diagnosis of mental illnesses other than MDD or anxiety disorders; 9. Previously, there was no response to electroconvulsive therapy;

Design outcomes

Primary

MeasureTime frame
Near infrared functional imaging;EEG data;

Countries

China

Contacts

Public ContactLiu Fang

Chengdu High-tech Zone Women and Children's Hospital/West China Second University Hospital of Sichuan University

705836059@qq.com+86 177 1613 9156

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026